Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis.
ACTRIMS-ECTRIMS 2014 -- Day 1, afternoon
Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations.
Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis.
HLA-DRB1*1501 tagging rs3135388 polymorphism is not associated with neuromyelitis optica.
Synthetic Biologics Reports UCLA Announcement of Preliminary Positive Topline Efficacy and Safety Results from Investigator-Led Phase II Study of Trimesta™ for RRMS
Blood Brain Barrier Meeting
Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients.
FGF2 and FGFR1 signaling regulate functional recovery following cuprizone demyelination.
28th Congress of European Committee for Treatment and Research in Multiple Sclerosis Congress
Nancy Davis Foundation Annual MS Expo and Health Forum
Quantifying the early stages of remyelination following cuprizone-induced demyelination.
Biogen Idec reports positive top-line results from Phase 2 anti-LINGO-1 trial in people with acute optic neuritis
Webinar: Solutions for Genome Editing: TALEN, CRISPR, & Safe Harbor Integration
Episode 38 with Dr. Joseph Berger on progressive multifocal leukoencephalopathy
Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS.
GlaxoSmithKline Protocol Summaries: Firategrast
TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.
Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination.
Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?
De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected.
Sex differences in autoimmune diseases.
Testosterone treatment in multiple sclerosis: a pilot study.
IL-2Rβγ-signaling contributes to regulatory T cell maintenance and stability in daclizumab HYP-treated RRMS patients
Episode 56 with Dr. Gavin Giovannoni, on early phase 3 results of ocrelizumab, the first experimental drug to show some benefit in a progressive form of multiple sclerosis in a major trial

Pages